Tissue Localization and Extracellular Matrix Degradation by PI, PII and PIII Snake Venom Metalloproteinases: Clues on the Mechanisms of Venom-Induced Hemorrhage by Herrera, C et al.
Tissue localization and extracellular matrix degradation by PI, PII and PIII
snake venom metalloproteinases: clues on the mechanisms of venom-
induced hemorrhage.
Herrera, C; Escalante, T; Voisin, MB; Rucavado, A; Morazán, D; Macêdo, JK; Calvete, JJ;
Sanz, L; Nourshargh, S; Gutiérrez, JM; Fox, JW
 
 
 
 
 
http://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0003731
 
 
For additional information about this publication click this link.
http://qmro.qmul.ac.uk/xmlui/handle/123456789/9775
 
 
 
Information about this research object was correct at the time of download; we occasionally
make corrections to records, please therefore check the published record when citing. For
more information contact scholarlycommunications@qmul.ac.uk
RESEARCH ARTICLE
Tissue Localization and Extracellular Matrix
Degradation by PI, PII and PIII Snake Venom
Metalloproteinases: Clues on the Mechanisms
of Venom-Induced Hemorrhage
Cristina Herrera1,2, Teresa Escalante2, Mathieu-Benoit Voisin3, Alexandra Rucavado2,
Diego Morazán2, Jéssica Kele A. Macêdo4, Juan J. Calvete5, Libia Sanz5,
Sussan Nourshargh3, José María Gutiérrez2*, Jay W. Fox4*
1 Instituto de Investigaciones Farmacéuticas, Facultad de Farmacia, Universidad de Costa Rica, San José,
Costa Rica, 2 Instituto Clodomiro Picado, Facultad de Microbiología, Universidad de Costa Rica, San José,
Costa Rica, 3 William Harvey Research Institute, Barts and The London School of Medicine and Dentistry,
Queen Mary University of London, London, United Kingdom, 4 University of Virginia School of Medicine,
Charlottesville, Virginia, United States of America, 5 Instituto de Biomedicina de Valencia, Consejo Superior
de Investigaciones Científicas, Valencia, Spain
* jose.gutiérrez@ucr.ac.cr (JMG); jwf8x@virginia.edu (JWF)
Abstract
Snake venom hemorrhagic metalloproteinases (SVMPs) of the PI, PII and PIII classes were
compared in terms of tissue localization and their ability to hydrolyze basement membrane
components in vivo, as well as by a proteomics analysis of exudates collected in tissue in-
jected with these enzymes. Immunohistochemical analyses of co-localization of these
SVMPs with type IV collagen revealed that PII and PIII enzymes co-localized with type IV
collagen in capillaries, arterioles and post-capillary venules to a higher extent than PI
SVMP, which showed a more widespread distribution in the tissue. The patterns of hydroly-
sis by these three SVMPs of laminin, type VI collagen and nidogen in vivo greatly differ,
whereas the three enzymes showed a similar pattern of degradation of type IV collagen,
supporting the concept that hydrolysis of this component is critical for the destabilization of
microvessel structure leading to hemorrhage. Proteomic analysis of wound exudate re-
vealed similarities and differences between the action of the three SVMPs. Higher extent of
proteolysis was observed for the PI enzyme regarding several extracellular matrix compo-
nents and fibrinogen, whereas exudates from mice injected with PII and PIII SVMPs had
higher amounts of some intracellular proteins. Our results provide novel clues for under-
standing the mechanisms by which SVMPs induce damage to the microvasculature and
generate hemorrhage.
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Author Summary
Local and systemic hemorrhage are typical manifestations of envenomings by viperid
snakes. Hemorrhagic activity is due to the action of snake venom metalloproteinases
(SVMPs) in the microvasculature, especially in capillaries. There are large differences in
the hemorrhagic potential of SVMPs, depending on their domain composition. The pres-
ent study compared PI, PII and PIII hemorrhagic SVMPs for their tissue distribution and
their ability to cleave proteins of the extracellular matrix (ECM), especially those of the
basement membrane (BM) that provides mechanical stability to microvessels. Observa-
tions indicate that PII and PIII SVMPs, which exert a high hemorrhagic activity, are pref-
erentially located in microvessels, whereas PI SVMP is distributed in a more widespread
fashion in the tissue. In addition, when these toxins are injected at doses that induce a sim-
ilar hemorrhagic effect, they cleave type IV collagen to a similar extent, showing differ-
ences in the cleavage patterns of other ECM components, such as laminin, nidogen and
type VI collagen. The analysis of the exudates resultant from the action of these SVMPs in
the tissue revealed many similarities and some differences in the exudate proteomes. Over-
all our results indicate that hydrolysis of type IV collagen is a key event in the onset of
microvessel damage, and that the ability of SVMPs to bind to microvessels greatly deter-
mines their hemorrhagic potential.
Introduction
Zinc-dependent enzymes of the M12 reprolysin family of metalloproteinases are abundant
components in the venoms of snakes, especially from species classified in the family Viperidae
[1]. Snake venommetalloproteinases (SVMPs) have undergone a complex process of molecular
evolution after the recruitment in the venom gland of an ADAM-like enzyme, an event that oc-
curred before the diversification of the advanced families of the superfamily Colubroidea [2–
4]. Further events included gene duplication, domain loss and neofunctionalization through
mutations in regions coding for surface-exposed residues [5]. Such complex evolutionary land-
scape has generated a great diversity of SVMPs in snake venoms with a wide spectrum of bio-
logical activities. In addition, post-transcriptional and post-translational events further
contribute to determine the final pattern of SVMPs in a particular venom [6].
On the basis of domain constitution, three main classes of SVMPs occur in viperid venoms
[1]: class PI is comprised by enzymes containing only the metalloproteinase domain in the ma-
ture protein, including the canonical zinc-binding motif HEXXHXXGXXH followed by a Met-
turn motif. SVMPs of the class PII present a disintegrin domain following the metalloprotei-
nase domain; in many enzymes, this disintegrin domain is proteolytically released from its pre-
cursor [1,7]. Class PIII SVMPs comprise, in addition to the metalloproteinase domain, a
disintegrin-like (Dis-like) domain followed by a cysteine-rich domain (Cys-rich). Post-transla-
tional processing of precursors of some PIII metalloproteinases results in the release of the Dis-
like and Cys-rich domains (DC fragment) [1]. Further heterogeneity arises from the fact that
some PII and PIII SVMPs occur as dimers, and some PIII enzymes are comprised of an addi-
tional subunit constituted by a C-type lectin-like protein, linked to the main proteinase chain
by disulfide bonds [1].
These variations in domain composition have implications for the function of these en-
zymes and for their toxic profile. The non-metalloproteinase domains in PII and PIII SVMPs
contain exosites that determine the binding of these enzymes to particular targets in the extra-
cellular matrix (ECM), especially in microvessels, or in the plasma membrane of cells [8–14].
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Immunohistochemical observations revealed a distinct pattern of distribution of PI and PIII
SVMPs in the tissue [8]. In addition, the presence of these domains may prevent the inhibition
of these SVMPs by the plasma inhibitor α2-macroglobulin [15,16], thus allowing them to act
systemically after gaining access to the bloodstream. A potential consequence of the presence
of these non-metalloproteinase domains is that PIII SVMPs generally have a greater hemor-
rhagic potency than PI SVMPs [17,18]. Moreover, although few PII SVMPs have been charac-
terized in terms of hemorrhagic activity, two of them have been demonstrated as highly active
hemorrhagic toxins [16,19]. Despite experimental evidence of differential binding of PI and
PIII SVMPs to tissue structures in vivo and ECM proteins in vitro, a detailed comparative anal-
ysis of location of PI, PII and PIII hemorrhagic SVMPs in tissue is lacking.
The ability of hemorrhagic SVMPs to degrade basement membrane (BM) components has
been known for many years, and it has been hypothesized that hydrolysis of BM proteins is a
key event in the onset of microvascular damage and hemorrhage by SVMPs [20–23]. When
comparing the patterns of hydrolysis of BM components in vivo and in vitro between hemor-
rhagic and non-hemorrhagic PI SVMPs from Bothrops sp venoms, a striking difference was
found regarding degradation of type IV collagen, as this BM component was hydrolyzed by the
hemorrhagic toxin but not by the non-hemorrhagic SVMP [22]. Since type IV collagen plays a
key role in the mechanical stability of BM and hence of the capillary vessel structure [24–27],
this observation is likely to have relevant functional implications regarding the mechanism of
action of hemorrhagic SVMPs. It is therefore necessary to expand these studies to SVMPs of
the classes PII and PIII to assess whether the pattern of hydrolysis of ECM components, partic-
ularly those of the BM, is similar to the one described for PI SVMPs or whether enzymes of dif-
ferent classes present different degradation patterns.
The combination of complementary analytical experimental tools is necessary to gain a
deeper understanding on the mechanism of action of hemorrhagic SVMPs. In the present
study we explored the patterns of tissue localization of PI, PII and PIII SVMPs using an ex vivo
model in the cremaster muscle of mice and immunofluorescence confocal microscopy. In par-
allel, the patterns of BM protein degradation on skin and muscle in vivo were investigated by
immunochemical analysis of tissue homogenates and exudates. Finally, a proteomic analysis of
exudate collected from the tissue affected by the SVMPs was performed. Such proteomic analy-
sis constitutes a ‘window’ through which details of toxin-induced tissue alterations, unobserved
by more traditional histological analyses, can be detected [28,29]. Our findings reveal a distinct
pattern of tissue localization of these SVMPs, with PII and PIII enzymes showing a close associ-
ation with the microvasculature, in contrast to PI SVMP, which had a more widespread distri-
bution in the tissue. Furthermore, variable patterns of degradation between the SVMPs were
observed for nidogen and laminin, whereas type IV collagen was hydrolyzed to a similar extent
by the three enzymes. In addition, proteomic analysis of exudate showed variations which sug-
gest differences in the pathological effects induced by these toxins. In summary, these observa-
tions provide for a new and more complete understanding the mechanism of microvessel
damage and hemorrhage induced by SVMPs.
Methods
Isolation of SVMPs and characterization of a new PIII from the venom of
C. simus
The PI SVMP BaP1 was isolated from the venom of Bothrops asper as described by Gutiérrez
et al. [30] andWatanabe et al. [31] by a combination of ion-exchange chromatography on
CM-Sepharose, followed by affinity chromatography on Affi-gel Blue. The dimeric PII SVMP
BlatH1 was purified from the venom of Bothriechis lateralis as described by Camacho et al.
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[16] by ion-exchange chromatography on DEAE-Sepharose, followed by hydrophobic interac-
tion chromatography on Phenyl Sepharose and gel filtration on Superdex 200 10/300GL. A
novel PIII SVMP was purified from the venom of adult specimens of the Central American rat-
tlesnake Crotalus simus. The venom was fractionated by ion-exchange chromatography on a
DEAE-Sepharose column using a BioLogic LP chromatography system (Bio-Rad). After wash-
ing the column with initial buffer (0.25 mM Tris-HCl, 2.5 mM CaCl2, pH 7.0), a linear gradient
was developed from 0 to 0.35 M NaCl in the starting buffer. The last fraction eluted, consisting
mainly of a 55 kDa hemorrhagic toxin, was further purified by gel filtration chromatography
on a SuperdexTM 200 10/300GL (GE Healthcare, LifeSciences) column (10 x 300 mm) previ-
ously equilibrated with 0.05 M Tris-HCl, 5 mM CaCl2, pH 5.8, buffer using an ÄKTA FPLC
(GE Healthcare, LifeSciences).
Homogeneity and molecular mass of the C. simus SVMP were determined by SDS-poly-
acrylamide gel electrophoresis (SDS-PAGE), run under reducing and non-reducing conditions
[32]. SDS-PAGE electrophoresis was performed on 15% Tris-HCl polyacrylamide gel and
staining was performed, either with Coomassie Brilliant Blue for total protein, or with Pro-Q
Emerald 300 Glycoprotein Stain Kit (Molecular Probes) for detection of carbohydrates. Proteo-
lytic activity was assessed on azocasein (Sigma) as described by Wang et al. [33]. Hemorrhagic
activity was evaluated by injecting various amounts of the SVMP intradermally in mice and
measuring, after 2 h, the diameter of the hemorrhagic lesion in the internal side of the skin
[34]. The Minimum Hemorrhagic Dose (MHD) corresponds to the amount of enzyme that in-
duces a hemorrhagic spot of 10 mm diameter 2 h after injection. In addition, the ability of this
enzyme to induce pulmonary hemorrhage was assessed by injecting 50 μg of the enzyme by the
intravenous route in mice. One hour after injection, mice were sacrificed by an overdose of
xylazine and ketamine, and lungs were dissected out and routinely processed for embedding in
paraffin and staining with hematoxylin-eosin.
For tryptic peptide mapping and internal peptide sequence determination, purified PIII-SVMP
was excised from a Coomassie Brilliant Blue-stained SDS-PAGE and subjected to automated re-
duction (10mM dithiothreitol) and alkylation (50mM iodacetamide), followed by overnight tryp-
sin digestion (66 ng/μL of sequencing-grade porcine trypsin (Promega) in 25 mM ammonium
bicarbonate, 10% acetonitrile; 0.25 μg/sample) in a ProGestTM Protein DigestionWorkstation
(Genomics Solutions) following manufacturer's instructions. For peptide sequencing, the protein
digest mixture was loaded in a nanospray capillary column and subjected to electrospray ioniza-
tion (ESI) mass spectrometric analysis using a QTrapTM 2000mass spectrometer (Applied Biosys-
tems) equipped with a nanospray source (Protana, Denmark). Doubly- or triply-charged ions
were analyzed in Enhanced Resolution MS mode and the monoisotopic ions were fragmented
using the Enhanced Product Ion tool with Q0 trapping. Enhanced Resolution was performed at
250 amu/s across the entire mass range. Settings for collision-induced dissociation MS/MS experi-
ments were as follows: Q1- unit resolution; Q1-to-Q2 collision energy—30–40 eV; Q3 entry barri-
er—8 V; LIT (linear ion trap) Q3 fill time—250 ms; and Q3 scan rate—1000 amu/s. Product ion
spectra were interpreted manually.
The complete amino acid sequence of C. simus PIII SVMP was determined by a combina-
tion of tryptic peptide MS/MS sequencing and cDNA cloning from a venom gland cDNA li-
brary previously constructed and used for profiling the venom gland transcriptomes of Costa
Rican snakes by 454 pyrosequencing [35]. The amplification mixture contained, in a final vol-
ume of 50 μL: 1 μL of cDNA library; 1 μL of a 10 μM stock solution of each, forward (Fw:
5-AAC CCC TTC AGA TTC GTT GAG-3´) and reverse (Rv: 3’-ATA GGC TGT AGC CAC
ATC AAC-5') primers derived from the amino acid sequences NPFRFVE and VDVATAY, re-
spectively, determined by de novoMS/MS tryptic ion sequencing, these amino acid sequences
are highly conserved in the N- and C-termini of PIII-SVMPs, respectively; 0.25 μL of DNA
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polymerase (GoTaq, Promega); 1 μL of 10 mM dNTPs; 2 μL of 25 mMMgCl2; 5 μL of 5x buff-
er; and 13.75 μL of DNAse-free deionized water. The PCR protocol included initial denatur-
ation at 94°C for 10 min, followed by 35 cycles of denaturation (10 s at 94°C), annealing (45 s
at 55°C) and extension (120 s at 72°C), and a final extension for 7 min at 72°C. The amplified
fragment was purified from an agarose gel using the Illustra GFX PCR DNA and Gel Band Pu-
rification kit (GE Healthcare) and cloned in a pCR-XL-TOPO vector (Invitrogen). E. coliDH5
cells (Novagen, Madison, WI, USA) were transformed by electroporation using an Eppendorf
2510 electroporator following the manufacturer´s instructions. Positive clones, selected by
growing the transformed cells in Luria-Broth (LB) medium containing 10 μg/ml ampicillin,
were confirmed by PCR amplification using the above primers, and the PCR-amplified frag-
ments were sequenced using an Applied Biosystems model 377 DNA sequencer.
Ethics statement
All in vivo experiments were performed in CD-1 mice. The experimental protocols involving
the use of animals in this study were approved by the CICUA (University of Costa Rica) and
meet the International Guiding Principles for Biomedical Research Involving Animals
(CIOMS).
Experiments ex vivo
Immunolocalization of SVMPs in muscle tissue. The mouse cremaster muscle was used
to study the distribution and immunolocalization of the SVMPs because it is possible to obtain
high resolution images of longitudinal blood vessels by confocal microscopy due to the trans-
parency and thinness of this tissue. Groups of three male mice were killed by cervical disloca-
tion and the cremaster muscle was dissected out. The isolated muscles were incubated in PBS
for 15 min with either BaP1 (PI, 30 μg), BlatH1 (PII, 3.5 μg) or CsH1 (PIII, 15 μg) SVMPs la-
beled with Alexa Fluor 647 according to the Microscale Protein Labeling Kit (Molecular Probes
A30009). These doses were selected as to induce a hemorrhage in the cremaster muscle of simi-
lar intensity to that described previously by intravital microscopy for the PI SVMP BaP1 [36].
Control tissues were incubated with unlabeled toxins. After incubation, tissues were washed
with PBS and fixed with 4% paraformaldehyde in PBS for 30 min at 4°C. Fixed whole tissues
were incubated for 4 h at room temperature in blocking and permeabilization solution (12.5%
goat serum, 12.5% fetal bovine serum and 0.5% Triton X-100 in PBS). Then, the tissues were
immunostained overnight at 4°C with rabbit anti-collagen type IV polyclonal antibody at a di-
lution of 1:100 (Abcam ab19808), and Cy3-labeled mouse anti-actin α smooth muscle mono-
clonal antibody at a dilution of 1:200 (clon 1A4, Sigma C6198) to visualize the vascular
basement membrane and smooth muscle/pericytes, respectively. After three washes in PBS, tis-
sues were incubated for 4 h at 4°C with goat anti-rabbit polyclonal antibody labeled with Alexa
Fluor 488 at a dilution of 1:200 (Invitrogen A11034). In order to ascertain whether labeling of
SVMPs had an effect on their enzymatic activity, proteolytic activity of the labeled enzymes
was quantified on gelatin with the EnzChek Gelatinase Assay Kit (Molecular Probes E-12055)
at different times during 24 h.
Immunostained tissues were mounted on glass slides and visualized using a Zeiss LSM 5
Pascal laser-scanning confocal microscope (Carl Zeiss Ltd) incorporating a 10X objective (nu-
merical aperture 0.3) and 63X oil objective (numerical aperture 1.4). At least four images of
post-capillary venules (PCV), arterioles and capillaries per tissue were taken in 3 dimensions at
a resolution of 1,024 × 1,024 dpi corresponding to a voxel size of 0.14 × 0.14 × 0.38 μm in the
X × Y × Z plans, respectively using the 63X objective. Three-dimensional reconstitution of the
images and analysis of co-localization of the SVMPs with collagen IV were carried out using
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IMARIS x64 7.4.2 image analysis software, which employs the approach developed by Costes
et al. [37]. A region of interest (ROI) in the pixel intensity of 10 was defined to calculate the
threshold for each label with the automatic function of the software. The program IMARIS an-
alyzes the intensity of each label by voxels defined as a prism with the pixel in the base and the
thickness of the confocal section in the height. The results of co-localization were expressed as
the percentage of material co-localized which takes into account the number of voxels co-local-
ized and the Pearson´s correlation coefficient, which reflects the correlation between intensities
in the co-localized voxels. The Pearson’s coefficient varies between +1 and -1, where values
near 1 indicate a direct correlation, and values near 0 indicate no correlation. The percentage
of co-localization may overestimate the extent of co-localization, while the Pearson’s coefficient
may underestimate the extent of co-localization since it takes into account that the intensity of
the two labels varies together. Hence, it is important to analyze both values in co-localization
studies.
Experiments in vivo
Immunochemical detection of ECM proteins in the skin and exudate. Groups of five
mice were injected intradermally in the ventral abdominal region with either BaP1 (PI, 75 μg),
BlatH1 (PII, 1.5 μg) or CsH1 (PIII, 35 μg) SVMPs, dissolved in 100 μL of PBS. These doses
were selected as to induce a similar hemorrhagic area in the injected skin, since these enzymes
have highly different hemorrhagic activity, i.e. Minimum Hemorrhagic Doses [16,30], [this
work]. The control group received 100 μL of PBS alone. After 15 min, mice were sacrificed by
CO2 inhalation, their skin was removed, and an area of 12 mm diameter in the site of the injec-
tion was dissected out. In order to prepare a pool, all skin fragments from each treatment were
combined the placed in liquid nitrogen and pulverized until fine particles were obtained. Each
pool was resuspended in 1.5 mL of extraction buffer (25 mM Tris-HCl, 150 mMNaCl, 8 M
urea, 40 mM EDTA, 1% Triton X-100, 0.1% SDS, pH 7.4) with a tablet of protease inhibitor
cocktail (Roche) per 10 mL of buffer. One hour after incubation under stirring at 4°C, samples
were centrifuged at 5,200 g for 5 min and the supernatant was diluted 1:2 with water and stored
at -70°C until Western blot analysis was performed.
In another set of experiments, groups of five mice were injected in the right gastrocnemius
with either BaP1 (PI, 75 μg), BlatH1 (PII, 3 μg) or CsH1 (PIII, 50 μg) SVMPs, dissolved in
50 μL of PBS. These doses were selected as they induce a similar extent of hemorrhagic activity
in muscle. After 15 min of injection, mice were sacrificed by CO2 inhalation, and a 5 mm inci-
sion was made with a scalpel in the skin overlying the injected muscle. Immediately, the sec-
tioned skin was opened and a heparinized capillary tube was introduced under the skin to
collect the wound fluid [28]. An approximate volume of 20–50 μL of exudate was collected
from each mouse. Exudate samples were then pooled and lyophilized.
For immunoblotting, 10–20 μL of each skin homogenate sample, or 100 μg protein of each
exudate sample, were separated under reducing conditions on 4–15% Tris–HCl SDS-PAGE
gradient gels, and transferred to nitrocellulose membranes. Immunodetection was performed
by incubating the membranes overnight at 4°C under stirring with either rabbit anti-collagen
type VI polyclonal antibody at a dilution of 1:2,000 (Millipore AB7821), rabbit anti-collagen
type IV polyclonal antibody at a dilution of 1:1,000 (Abcam ab6586), rabbit anti-laminin poly-
clonal antibody at a dilution of 1:500 (Abcam ab11575), or rabbit anti-nidogen 1 polyclonal an-
tibody at a dilution of 1:3,000 (Abcam ab14511). The anti-GAPDH antibody at a dilution of
1:1,000 (Abcam ab9485) was used as loading control for immunoblotting of the skin homoge-
nates samples. The reaction was detected using an anti-rabbit peroxidase antibody at a dilution
of 1:10,000 (Jackson ImmunoResearch) and the chemiluminescent substrate Lumi-Ligth
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(Roche). The images were obtained with the ChemiDoc XRS+ System (BioRad) and the analy-
sis was performed with the ImageLab software (BioRad).
Analysis of the proteomics of exudates
Lyophilized wound exudate samples were re-suspended in water and protein quantification
was performed using micro BCA protein assay kit (Thermo Scientific) Twenty micrograms of
protein were then resuspended in Laemmli buffer, applied to a 12% precast electrophoresis gel
(Bio-Rad), separated, and stained with Coomassie Brilliant Blue. Gel lanes were cut in ten
equal size slices. Gel slices were destained for 3 h and the proteins reduced (10 mMDTT) and
alkylated (50 mM iodoacetamide) at room temperature. Gel slices were washed with 100 mM
ammonium bicarbonate, dehydrated with acetonitrile and dried in a speed vac. Hydration of
the slices was performed with a solution of Promega modified trypsin (20 ng/μL) in 50 mM
ammonium bicarbonate for 30 min on ice. Excess trypsin solution was removed and the diges-
tion was carried on for an additional 18 h at 37°C. Tryptic peptides were twice extracted from
gel slices with 30 μL of a 50% acetonitrile/5% formic acid solution. The combined extracts were
dried to a volume of 15 μL for mass spectrometric analysis. LC/MS/MS was performed using a
Thermo Electron Orbitrap Velos ETD mass spectrometer system. Analytical columns were
fabricated in-house by packing 0.5 cm of irregular C18 Beads (YMC Gel ODS-A, 12 nm, I-10-
25 um) followed by 7.5 cm Jupiter 10 μm C18 packing material (Phenomenex, Torrance, CA)
into 360 x 75 μm fused silica (Polymicro Technologies, Phoenix, AZ) behind a bottleneck. Sam-
ples were loaded directly onto these columns for the C18 analytical runs. Aliquots of 7 μL were
loaded onto the column for each analysis and eluted into the mass spectrometer at 0.5 μL/min
using an acetonitrile/0.1M acetic acid gradient (2–90% acetonitrile over 1 h). The instrument
was set to Full MS (m/z 300–1600) resolution of 60,000 and programmed to acquire a cycle of
one mass spectrum followed by collision-induced dissociation (CID) MS/MS performed in the
ion trap on the twenty most abundant ions in a data-dependent mode. Dynamic exclusion was
enabled with an exclusion list of 400 masses, duration of 60 seconds, and repeat count of 1.The
electrospray voltage was set to 2.4 kV, and the capillary temperature was 265°C.
Peak lists were generated from the raw data using the Sequest search algorithm in Proteome
Discoverer 1.4.1 against the Uniprot Mouse database from July 2014. Spectra generated were
searched using carbamidomethylation on cysteine as a fixed modification, oxidation of methio-
nine as a variable modification, 10 ppm parent tolerance and 1 Da fragment tolerance. All hits
were required to be fully tryptic. The results from the searches were exported to Scaffold (ver-
sion 4.3.2, Proteome Software Inc., Portland, OR). Scaffold was used to validate MS/MS based
peptide and protein identifications and to visualize multiple datasets in a comprehensive man-
ner. Protein identifications were filtered using Xcorr cutoff values dependent on charge state
(+1>1.8, +2>2.2, +3>2.5 and +4>3.5). Confidence of protein identification in Scaffold is dis-
played as a Probability Legend with green coloration indicative of over 95% confidence and yel-
low as 80% to 94% confidence. Relative quantization of proteins was accomplished by
summing all data from the 10 gel slices for a particular sample in Scaffold and then displaying
the Quantitative Value from the program. This number gives an average total of non-grouped
spectral counts for a protein divided by the total non-grouping spectral counts for the 10 mass
spectral runs from the gels slices from each lane (http://www.proteomesoftware.com/). This
format of presentation allows for a relative quantitative comparison between a specific protein
from different samples and to a certain degree gives some measure of relative abundance be-
tween proteins generated from the mass spectrometric analysis of the 10 gel slices for a particu-
lar exudate sample. Portions of the data were further analyzed manually to determine if mass
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spectra were derived from proteins migrating in the gel at their expected molecular mass or at
a lower mass.
Results
Characterization of a new PIII SVMP from the venom of C. simus
Through a combination of ion-exchange chromatography on DEAE-Sephadex and gel filtra-
tion, a novel hemorrhagic SVMP was purified to homogeneity from the venom of adult speci-
mens of the Central American rattlesnake C. simus (Fig 1A and 1B). This SVMP is hereby
named CsH1. It is a monomeric glycosylated protein with a molecular mass of 55 kDa (Fig 1A
and 1B). The cDNA-deduced amino acid sequence was identified by BLAST analysis as Gen-
Bank accession number DQ164403 (the species Crotalus simus was previously named Crotalus
durissus durissus), and various tryptic peptide ion sequences gathered by de novoMS/MS se-
quencing of an in-gel digested Coomassie Brilliant Blue-stained SDS-PAGE band of the puri-
fied PIII SVMP (Table 1) confirmed the assignment. The enzyme possesses a zinc
Fig 1. (A), (B) SDS-PAGE ofCrotalus simus PIII SVMP and crude venom. Samples were run on a 12%
gel, and stained with (A) Coomassie blue or (B) Pro-Q Emerald 300 glycoprotein stain (Molecular probes).
Lane 1: SVMP, reducing conditions; lane 2: SVMP, non-reducing conditions; lane 3:Crotalus simus venom,
reducing conditions; lane 4: Crotalus simus venom, non-reducing conditions. The P-III metalloproteinase is a
major component of the venom; it is glycosylated and has a molecular mass of 55 kDa. (C) and (D) Light
micrographs of sections of lung tissue frommice injected intravenously with either saline solution (C) or
100 μg of C. simus PIII SVMP. Mice were sacrificed one h after injection and tissue samples were obtained
and routinely processed for embedding in paraffin and further staining with hematoxylin-eosin. Notice
prominent hemorrhage in the pulmonary tissue in (D) (arrow). 125 X.
doi:10.1371/journal.pntd.0003731.g001
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metalloproteinase domain, a disintegrin-like domain and a cysteine-rich domain, hence corre-
sponding to a PIII SVMP. The SVMP has proteolytic activity on azocasein and was hemorrhag-
ic using the mouse skin assay, with a MHD of 2.2 μg. Both proteolytic and hemorrhagic
activities were abrogated by incubation with EDTA. The enzyme was also able to induce hem-
orrhage in lungs after intravenous injection (Fig 1C and 1D); thus it induces both local and
systemic hemorrhage.
Inmunolocalization of SVMPs in the tissue
When equi-hemorrhagic amounts of either PI, PII or PIII SVMPs were incubated for 15 min
with the isolated cremaster muscles ex vivo, a clear difference in the distribution of the toxins
was observed (Fig 2A). BlatH1 (PII) and CsH1 (PIII) SVMPs were preferentially localized in
the basement membrane of blood vessels, as evidenced by co-localization with collagen IV. In
contrast, localization of BaP1 (PI) SVMP was observed widespread in the tissue and to a lesser
extent in the vascular basement membrane (Fig 2A). No fluorescence was detected in the con-
trol tissues incubated with unlabeled SVMPs. This localization of BlatH1 (PII) and CsH1 (PIII)
SVMPs was noted in post-capillary venules (PCV) and also in arterioles and capillaries (Fig
2B). The proteolytic activity on gelatin of the three SVMPs after labeling with Alexa Fluor 647
was between 75–85% as compared to control unlabeled enzymes, thus indicating that labeled
SVMPs remained functionally active.
The analysis of co-localization (Fig 2C and 2D) showed a higher percentage of co-localiza-
tion (around 40%) and Pearson’s coefficient (around 0.4) for BlatH1 (PII) and CsH1 (PIII)
SVMPs with collagen IV of the vascular basement membrane in PCV, arterioles, and capillaries
as compared with BaP1 (PI) SVMP (p<0.001). No significant differences were observed be-
tween co-localization of PII and PIII SVMPs with collagen IV in the basement membrane of
Table 1. Tryptic peptide ion sequences obtained by de novoCID-MS/MS sequencing of Crotalus simus PIII SVMP.
m/z Z Amino acid sequence
275.3 2+ CADGK
291.8 2+ JYCK
354.7 2+ SGTECR
359.8 2+ TDJJTR
401.3 2+ GMVJPGTK
417.3 2+ NNDDJDK
467.8 2+ ZKYNPFR
526.3 2+ GNYYGYCR
615.8 2+ DNSPGQNNPCK
649.9 2+ MFYSNEDEHK
760.8 3+ YMYJHVAJVGJEJWSNEDK
766.4 2+ VJGJAYVGSMCHPK
801.3 2+ MYEJANTVNDJYR
776.2 2+ VCSNGHCVDVATAY
885.4 2+ SGSQCGHGDCCEQCK
684.6 3+ JTVKPEAGYTJNAFGEWR
869.8 3+ ZKYNPFRFVEJVJVVDKAMVTK
926.3 3+ ASMSECDPAEHCTGQSSECPADVFHK
J, Isoleucine (I) or Leucine (L); Z, pyroglutamic acid (2-oxo-pyrrolidone carboxylic acid). Cysteine residues (C) are carbamidomethylated.
doi:10.1371/journal.pntd.0003731.t001
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arterioles, capillaries, and PCV. Moreover, no significant differences were observed between
co-localization of each SVMPs in the basement membrane of arterioles, capillaries, and PCV.
Immunochemical analysis of BM-associated proteins in the skin and in
exudates
Hemorrhagic lesions of similar extent and intensity were observed in the skin of mice 15 min
after the injection of 75 μg, 1.5 μg and 35 μg of the PI, PII and PIII SVMP, respectively, as ex-
pected when accounting for the highly different MHDs of these SVMPs. Homogenates of the
sections of hemorrhagic skin were analyzed by immunoblot for the detection of several ECM
components. With regard to the immunodetection of type IV collagen, samples from control
skin injected with saline solution showed a predominant band of 107 kDa, with additional faint
bands of 216 kDa, 176 kDa, 165 kDa, 117 kDa, and 97 kDa (Fig 3A). A conspicuous degradation
band of 97 kDa was observed in samples from skins injected with the three SVMPs, together
with a reduction in the intensity of the 107 kDa band (Fig 3A). The intensity of the 97 kDa band
had the following order: PI> PII> PIII. Regarding type VI collagen, PI SVMP induced a
Fig 2. Immunolocalization of SVMPs with vascular basement membrane on cremaster muscle ex vivo. Isolated cremaster muscles were incubated for
15 min with equi-hemorrhagic amounts of either BaP1 (PI, 30 μg), BlatH1 (PII, 3.5 μg) or CsH1 (PIII, 15 μg) SVMPs labeled with Alexa Fluor 647 (blue).
Control tissues were incubated with the SVMPs without labeling and no fluorescence was detected. Whole tissues were fixed with 4% paraformaldehyde and
immunostained with anti-collagen IV following the secondary antibody labeled with Alexa Fluor 488 (green). Tissues were visualized in a Zeiss LSM 5 Pascal
laser-scanning confocal microscope. Three-dimensional reconstitution of the images and analysis of co-localization were carried out with the IMARIS x64
7.4.2 software as described in Methods. (A) Distribution of the SVMPs in the cremaster muscle tissue. Scale bar represents 150 μm. (B) White areas
represent co-localization of the SVMPs (blue) with collagen IV (green) of vascular basement membrane in PCV, arterioles, and capillaries. Scale bar
represents 20 μm. Results are expressed as the mean ± SEM of (C) percentage of material of SMVPs co-localized with collagen IV of vascular basement
membrane, and (D) Pearson´s correlation coefficient of at least four vessels type per tissue (n = 3). *p<0.001 when compared with BaP1 (PI) SVMP for post-
capillary venules (PCV), arterioles, and capillaries.
doi:10.1371/journal.pntd.0003731.g002
Fig 3. Western blot analysis of basement membrane components in skin homogenates.Groups of five mice were injected by intradermal route in the
ventral abdominal region with either BaP1 (PI, 75 μg), BlatH1 (PII, 1.5 μg), CsH1 (PIII, 35 μg) SVMPs or PBS (lane C). After 15 min, mice were sacrificed,
their skin was removed, and an area of 12 mm diameter was dissected out. Tissues of the same group were homogenized and centrifuged, and the
supernatant collected. Then, 10–20 μL of each skin homogenate sample were separated under reducing conditions on 4–15% Tris–HCl SDS-PAGE gradient
gels, and transferred to nitrocellulose membranes. Immunodetection was performed with (A) anti-collagen type IV, (B) anti-collagen type VI, (C) anti-laminin,
and (D) anti-nidogen 1. The anti-GAPDH antibody was used as loading control. The reaction was detected using an anti-rabbit peroxidase antibody and a
chemiluminescent substrate. Images were obtained with the ChemiDoc XRS+ System (BioRad).
doi:10.1371/journal.pntd.0003731.g003
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reduction in the intensity of the predominant band of 216 kDa, whereas the PII and PIII SVMPs
did not seem to hydrolyze this chain (Fig 3B). Degradation products of 160 kDa and 140 kDa
were observed in samples frommice injected with PI SVMP, whereas the intensity of these
bands in samples corresponding to the other two SVMPs was less pronounced (Fig 3B).
When laminin was immunodetected in skin homogenates, a predominant band of 167 kDa
was observed, with additional bands of 270 kDa and 350 kDa (Fig 3C). The PI SVMP induced
a greater hydrolysis of laminin, with the appearance of degradation products of 225 kDa and
50 kDa. The former band was not observed in samples from PII and PIII-treated mice (Fig 3C).
The three SVMPs differ in their degradation of nidogen (Fig 3D). Samples from skin of mice
injected with saline showed a predominant band of 135 kDa and few additional minor bands
(Fig 3D). PI SVMP induced extensive degradation of nidogen, as evidenced by the disappear-
ance of the 135 kDa band, and the appearance of a 47 kDa degradation band. A lower extent of
hydrolysis was observed with the PII and PIII SVMPs. There was a reduction in the 135 kDa
band, and the appearance of new bands of 100 kDa (in PIII SVMP) and of 47 kDa in samples
injected with either enzyme (Fig 3D).
Western blot analysis of exudates collected 15 min after injection of the enzymes revealed
both similarities and differences between the three SVMPs. A relatively similar pattern was
observed in the case of type IV collagen, with the presence of a predominant band of 90 kDa
(Fig 4A). Samples from mice injected with PI and PII SVMPs showed a band of 20 kDa, which
was not present in the case of PIII SVMP. In contrast, PIII SVMP generated a band of 140 kDa
not observed in the case of the other two enzymes. A highly variable pattern of immunoreactiv-
ity was observed in exudates when tested for type VI collagen degradation products (Fig 4B).
PI SVMP generated fragments of 225 kDa, 150 kDa, and 100 kDa. On the other hand, bands of
220 kDa and 200 kDa were observed in samples from PII SVMP-injected mice, and bands of
225 kDa, 200 kDa, 160 kDa, 140 kDa, and 40 kDa were present in exudates as a consequence of
Fig 4. Western blot analysis of basement membrane components in exudates collected from the gastrocnemius.Groups of five mice were injected in
the right gastrocnemius with either BaP1 (PI, 75 μg), BlatH1 (PII, 3 μg), or CsH1 (PIII, 50 μg) SVMPs. After 15 min, mice were sacrificed, a 5 mm incision was
made in the skin overlying the injected muscle, and a heparinized capillary tube was introduced under the skin to collect the wound exudate fluid; exudate
samples from a single treatment were then pooled. Afterwards, 100 μg of protein of each sample was separated under reducing conditions on 4–15% Tris–
HCl SDS-PAGE, and transferred to nitrocellulose membranes. Immunodetection was performed with (A) anti-collagen type IV, (B) anti-collagen type VI, (C)
anti-laminin, and (D) anti-nidogen 1. The reaction was detected using an anti-rabbit peroxidase antibody and a chemiluminescent substrate. Images were
obtained with the ChemiDoc XRS+ System (BioRad).
doi:10.1371/journal.pntd.0003731.g004
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the action of PIII SVMP (Fig 4B). In the case of laminin, exudate from mice injected with PI
SVMP showed bands of 275 kDa, 230 kDa, 200 kDa, 150 kDa, 105 kDa and 50 kDa (Fig 4C).
On the other hand, PII and PIII SVMPs generated a similar pattern of immunoreactive bands
of 275 kDa, 190 kDa, and 50 kDa, with an additional band of 140 kDa in the case of PIII SVMP
(Fig 4C). Analysis of nidogen in exudates showed the presence of immunoreactive bands of
140 kDa and 50 kDa in the case of PII SVMP, and of 50 kDa in the case of PIII SVMP, whereas
no immunoreactive bands were observed in the exudate of mice injected with PI SVMP
(Fig 4D).
Proteomic characterization of exudates
A similar protein pattern was observed when exudates were separated by 1D SDS-PAGE. From
the mass spectral analysis of the gel bands, a total of 297, 354 and 322 proteins, with protein
identification probability greater than 95% and minimum of two peptides, were identified in
exudates collected from mice injected with PI, PII and PIII SVMPs, respectively (S1 Table in-
cludes the complete report of all the proteins identified in the exudates). The most abundant
proteins identified based on their quantitative value (see http://www.proteomesoftware.com/
for full description of term) were analyzed. Proteins were classified within the following groups,
and subgroups: (a) serum proteins; (b) proteins of the coagulation cascade; (c) proteinase in-
hibitors of plasma; (d) intracellular proteins; (e) keratins; (f) ECM proteins; and (g) mem-
brane-associated proteins.
Serum proteins, including coagulation factors and proteinase inhibitors. S2–S4 Tables
depict the quantitative values of serum proteins, proteins of the coagulation cascade and pro-
teinase inhibitors, respectively. In general, similar values were observed for the vast majority of
proteins in exudates collected from mice injected with the three SVMPs, especially in those
with greatest quantitative values. Relatively minor differences were observed in the serum pro-
teins (S2 Table). The highest variations occurred in fibrinogen, with higher amounts in the
case of PI and PII SVMPs (S3 Table), and in some apolipoproteins, especially apolipoprotein
B-100, of which the PI SVMP induced great amounts in the exudate (S2 Table). No relevant
differences were noticed between SVMPs regarding the amounts of serum proteinase inhibitors
(S4 Table).
Intracellular proteins. Similar amounts of hemoglobin chains occurred in exudates ob-
tained from mice injected with the three SVMPs (S5 Table), as expected from the similar extent
of hemorrhage induced. Likewise, similar amounts of many other proteins characterized the
three types of exudates. However, there was a group of intracellular proteins in which higher
values were detected in exudates from mice injected with PII and PIII SVMPs (S5 Table). Re-
sults on keratins are presented separately (S6 Table) owing to the relevance of skin damage in-
duced by snake venoms. PII SVMP, and especially PI SVMP, induced a higher amount of
keratins in exudates than PIII SVMP (S6 Table).
ECM proteins. As shown in Table 2, no differences were observed in detected BM proteins
(heparin sulfate proteoglycan and nidogen). In contrast, there were differences in other ECM pro-
teins. There was a tendency for higher values in several proteins in exudates collected frommice
injected with the PI SVMP, such as tenascin, vitronectin, type VI collagen, type XIV collagen, type
III collagen, and thrombospondin-4 (Table 2). Proteolysis of ECM proteins was analyzed on the
basis of the range of molecular masses of the bands in SDS-PAGE gels. Identification of the vari-
ous proteins in ranges of molecular mass lower than the known mass of the native proteins were
considered degradation fragments, and the percentage of the total amount of each protein corre-
sponding to hydrolyzed bands was estimated. As shown in Table 3, Results indicate that various
types of collagens detected were degraded by the three SVMPs, with the exception of collagen type
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XIV, which was degraded 100% by the P-III, 33% by the PI and 0% by the PII. Regarding BM pro-
teins, heparan sulfate proteoglycan and nidogen-1 were similarly degraded by the three SVMPs.
Lumican was not degraded by any SVMP. Fibronectin was degraded to a higher extent by PI and
PIII than by PII. Thrombospondin 4 was degraded only by the PI SVMP.
Membrane-associated proteins. Seven membrane-associated proteins were detected in
the exudates. With one exception, the amounts of these proteins did not differ more than
3-fold in exudates from mice injected with the three types of SVMPs (S7 Table).
Table 2. Extracellular matrix proteins identified in wound exudate collected frommice injected with PI, PII or PIII SVMPs.
Protein Accession Number Mol. Mass Quantitative value
P-I P-II P-III
Fibronectin P11276 273 kDa 87 34 43
Tenascin X E9Q2T3 340 kDa 10 0 0
Basement membrane-specific heparan sulfate proteoglycan core protein B1B0C7 (+1) 469 kDa 4 3 2
Lumican P51885 38 kDa 8 7 7
Vitronectin P29788 55 kDa 7 5 2
Collagen alpha-1(I) chain P11087 138 kDa 3 4 4
Protein Col6a3 E9PWQ3 354 kDa 8 1 2
Collagen alpha-1(XIV) chain B7ZNH7 (+3) 193 kDa 9 3 2
Thrombospondin-4 Q9Z1T2 106 kDa 4 0 1
Nidogen-1 P10493 137 kDa 3 2 2
Collagen alpha-1(III) chain P08121 139 kDa 5 1 3
Collagen alpha-1(XV) chain A2AJY2 (+1) 138 kDa 0 0 3
Collagen alpha-2(I) chain Q01149 130 kDa 3 0 3
Values in bold and underlined correspond to proteins for which at least one SVMP induced an increment of at least three times as compared to another
SVMP.
doi:10.1371/journal.pntd.0003731.t002
Table 3. Degradation of extracellular matrix proteins identified in wound exudates (see Methods section for details).
Proteins Accession number Mol. mass Percentage degradation
PI PII PIII
Fibronectin P11276 273 kDa 45% 6% 76%
Tenascin X E9Q2T3 (+1) 340 kDa 11% a a
BM-specific heparan sulfate proteoglycan core protein B1B0C7 (+2) 469 kDa 50% 67% 50%
Vitronectin P29788 55 kDa 100% 20% 50%
Lumican P51885 38 kDa 0% 0% 0%
Thrombospondin-4 Q9Z1T2 106 kDa 75% a a
Nidogen-1 P10493 137 kDa 100% 100% 100%
Collagen alpha-1(XV) chain Col15a1 A2AJY2 (+3) 138 kDa 100% a 100%
Collagen alpha-1(I) chain Col1a1 P11087 138 kDa 100% 100% 100%
Collagen alpha-1(III) chain Col3a1 P08121 139 kDa 100% 100% 100%
Collagen alpha-1(XIV) Col14a1 B7ZNH7 (+3) 193 kDa 33% 0% 100%
Collagen alpha-2(I) chain Col1a2 Q01149 130 kDa 100% a 100%
Col6a3 (fragment) D3YWD1 (+2) 186 kDa 100% 100% a
a Not detected.
doi:10.1371/journal.pntd.0003731.t003
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Discussion
This study analyzed, from a comparative perspective, the tissue localization and the degrada-
tion of ECM proteins and other plasma and cellular proteins in the tissues of mice injected
with hemorrhagic PI, PII and PIII SVMPs. Since one of the main goals of this work was to gain
further insights into the mechanisms of SVMP-induced microvessel damage leading to hemor-
rhage, the doses of SVMPs injected were standardized as to induce the same extent of hemor-
rhagic lesions. It was hypothesized that, in these experimental conditions, the ECM proteins
whose hydrolysis is directly responsible for microvessel damage should be degraded to a similar
extent by the three enzymes.
It has been proposed that one of the basis for the higher hemorrhagic activity of PIII
SVMPs, as compared to PI enzymes, has to do with the ability of the former to locate in specific
sites in microvasculature of tissues [9,13,18]. This has been demonstrated for the case of jarar-
hagin, a PIII SVMP of the venom of Bothrops jararaca, where selective binding to microvessels
and a pattern of co-localization of jararhagin and type IV collagen was described [8]. This se-
lective binding is likely to depend on exosites located in the Dis-like and Cys-rich domains of
PIII SVMPs. In vitro studies have demonstrated that PIII SVMPs selectively bind to proteins
containing vonWillebrand factor (vWF) A domains, such as vWF, fibrillar-associated colla-
gens with interrupted triple helices (FACITs) and matrylins. Such interaction occurs between
these proteins and sequences located in the Cys-rich domain of PIII SVMPs [8,11–14]. In addi-
tion, the Dis-like domain of jararhagin might contain sequences that mediate its binding with
different types of collagen [9].
Our observations on the tissue localization of the three SVMPs in an ex vivomodel conclu-
sively demonstrate, using a quantitatively morphometric approach, the different pattern of dis-
tribution of PI and PIII SVMPs, since the former shows a more widespread pattern, whereas
the latter preferentially bind to the microvessels and clearly co-localizes with type IV collagen.
In addition, our study shows, for the first time, that a PII SVMP presents a pattern of distribu-
tion in the tissue highly similar to that of PIII enzymes, i.e. in the microvessels and co-localiz-
ing with type IV collagen. Hence, the dimeric PII SVMP, containing only metalloproteinase
and disintegrin domains, is preferentially located in the microvasculature. This is reasonable
given the high hemorrhagic activity of this PII SVMP [16]. The specific sequences in the PII
and PIII enzymes mediating the interaction to microvessels, and the specific sites in the vascu-
lature for interaction with SVMPs remain to be identified. The observed co-localization with
type IV collagen does not exclude possible binding to other BM components; however, our
findings support the concept that PII and PIII SVMPs preferentially co-localize with the BM.
These results support the hypothesis that the high hemorrhagic activity of PII and PIII SVMPs
is at least partially due to the selective localization of these enzymes in the BM of microvessels.
The co-localization of PII and PIII SVMPs with type IV collagen was observed not only in
capillary vessels, but also on arterioles and PCV, thus reflecting the localization of these
SVMPs in the BM of the three types of microvessels. The possible pathological effects of
SVMPs on these components of the microvasculature, in addition to capillaries, has not been
studied and deserve consideration in order to fully understand the vascular pathology in snake-
bite envenoming.
One puzzling issue has to do with the large variation in hemorrhagic activity between the
PII and PIII SVMPs, even though both present a similar pattern of distribution in the micro-
vasculature. This finding agrees with previous observations with Bothrops jararaca hemorrhag-
ic SVMPs in which there is a great difference in the hemorrhagic potential of PIII SVMPs [10].
These observations suggest that even though the high hemorrhagic activity of PII and PIII
SVMPs largely depends on their ability to selectively bind to microvessels, other factors also
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determine the hemorrhagic potential of these enzymes. Differences in the turnover rate of hy-
drolysis of relevant substrates in the BM, especially of type IV collagen, may play a key role. Al-
ternatively, PII and PIII SVMPs might present differences in the exosites in the Dis, Dis-like
and Cys-rich domains, which determine subtle variations in the localization of these enzymes
in the relevant substrates, with the consequent functional effects related to the proteolysis-in-
duced mechanical destabilization of BM structure. Another possible explanation has to do with
differences in the stability of these enzymes in the tissues, with more stable enzymes exerting a
higher hemorrhagic effect. This subject deserves further investigation.
Since the hemorrhagic activity of SVMPs is likely to depend on the hydrolysis of BM com-
ponents [8,18,22], particular attention was placed in this work to the analysis of degradation of
BM proteins. Proteomics analysis of exudate collected in the vicinity of the hemorrhagic areas
only detected perlecan and nidogen, and no differences were observed between the three
SVMP classes regarding BM proteins. No protein fragments of laminin and type IV collagen
were detected in this analysis. However, more sensitive immunochemical assessment of skin
and exudates revealed subtle variations which might shed light on the mechanisms of hemor-
rhagic activity. Different patterns of hydrolysis were observed regarding nidogen, laminin and
type VI collagen. In contrast, there were evident similarities between the three enzymes con-
cerning hydrolysis of type IV collagen. This has interesting implications because a previous
study identified type IV collagen as a likely candidate to play a key role in the onset of hemor-
rhagic activity, since hemorrhagic and non-hemorrhagic SVMPs differ in the extent of hydro-
lysis of this collagen [22]. Our present findings are therefore compatible with the hypothesis
that degradation of type IV collagen is critical for microvessel damage and hemorrhage. This in
turn agrees with the known role of this type of collagen in the mechanical stability of the BM
[24–27,38], mostly owing to the presence of a covalently-linked network formed by this BM
component [24]. Moreover, a genetic disease associated with mutations in the COL4A1 gene
and reduction in the expression of α1 subunit are associated with pathological alterations in
microvessels and hemorrhage in mice, and have been linked to hemorrhagic stroke in humans
[39]. In contrast to type IV collagen, hydrolysis of nidogen, laminin and type VI collagen by
the three SVMPs showed differences both in the degradation patterns and in the intensity of
the bands observed by immunoblotting of exudates, where the PI enzyme showed a more ex-
tensive degradation of these substrates. These observations, in the context of a similar extent of
hemorrhage by the three SVMPs, suggest that the hydrolysis of nidogen, laminin and type VI
collagen might not be directly associated with the onset of microvessel damage leading to hem-
orrhage but rather may be a general by-product of microvessel damage.
On the other hand, there were notorious differences in the amounts of other ECM proteins,
which are not BM components, in the proteomic analysis of exudates collected from mice in-
jected with the three toxins. In general, PI SVMP induced the appearance of higher amounts of
various ECM proteins in exudates. This observation may be due to two factors: since a higher
absolute amount of this enzyme was injected, owing to its lower hemorrhagic activity, there
was a higher proteolytic activity in the tissue, thus resulting in higher hydrolysis. The higher ex-
tent of hydrolysis in the case of the PI SVMP observed by immunoblotting of exudates sup-
ports this hypothesis. On the other hand, the presence of exosites in PII and PIII SVMPs may
contribute to their localization at specific targets in the ECM and on cell membranes, thus re-
ducing the probability of these enzymes to act in a widespread fashion on ECM components.
In contrast, the PI SVMP, being devoid of such exosites, would have less restriction to hydro-
lyze an ample spectrum of ECM substrates, as observed in our proteomics results.
As would be expected, the majority of ECM proteins detected in exudates corresponded to
proteolytic fragments, on the basis of their molecular mass. The different pattern of hydrolysis
by the SVMP of various ECM components, as detected by Western blot analysis, might be due
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to variations in the cleavage site preferences among these enzymes. Alternatively, this might
depend on the presence of exosites in the non-metalloproteinase domains, which target these
enzymes to different substrates in the ECM including BM or to different sequences in particu-
lar substrates, as observed by Serrano et al. [12,13].
In addition to ECM proteins, proteomic analysis of exudates allows the detection of serum,
intracellular and membrane-associated proteins, and these findings may shed light on the path-
ological action of SVMPs from a broader perspective. Similar quantitative patterns of plasma-
derived proteins were detected in exudates from mice injected with the three toxins. This
seems logical, as the presence of these proteins is largely a consequence of overt microvessel
damage by the action of these enzymes. Hence, extravasation of blood results in similar
amounts of serum plasma proteins, and of hemoglobin as well. An exception to this general
trend was observed with hydrolysis products of fibrinogen, which were in higher amounts in
exudates from animals injected with the PI SVMP. Since this enzyme has fibrinolytic activity
[30] and was injected in a higher dose than the other two SVMPs, this may have resulted in hy-
drolysis of the fibrin formed as a consequence of extravasation and clot formation.
When the amounts of intracellular proteins were compared in exudates, it was of interest
that the PI SVMP, and also the PII SVMP, induced a higher amount of keratins than PIII
SVMP. It is suggested that this reflects the ability of the former SVMPs to induce dermonecro-
sis and blistering which has been shown to be the case with this particular PI SVMP [40], but
has not been previously explored for the PII SVMP. It is noteworthy that the dermotoxic action
of the PII SVMP occurs when injected at a very low dose. On the other hand, there were several
other intracellular proteins whose amounts were higher in exudates collected from mice in-
jected with PII and PIII SVMPs. This suggests that these enzymes induce a higher cytotoxic ac-
tivity in various cell types in the tissue. The three SVMPs induced a similar extent of skeletal
muscle damage, as revealed by the similar amounts of the cytosolic muscle cell marker creatine
kinase in exudates; it has been suggested that hemorrhagic SVMPs induce myotoxicity as a
consequence of tissue ischemia [41]. The higher amounts of several intracellular markers in ex-
udates collected from PII and PIII SVMPs-injected mice may be due to the targeting of these
enzymes, through exosites present in the additional domains, to sites in the plasma membrane
or in the vicinity of cells, a hypothesis that remains to be investigated.
In conclusion, our findings demonstrate that PII and PIII hemorrhagic SVMPs co-localize
with type IV collagen in capillaries, PCVs and arterioles, whereas PI SVMP presents a more
widespread localization in the tissue. This difference in tissue localization is likely to be one of
the main reasons behind the higher hemorrhagic activity characteristic of PII and PIII SVMPs,
as compared to enzymes of the PI class. Furthermore, immunochemical results support the hy-
pothesis that hydrolysis of type IV collagen is likely to be a key event in SVMP-induced micro-
vessel damage and destabilization leading to hemorrhage.
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